After 3 months of air pollution exposure, researchers found individuals had higher blood glucose levels, higher levels of low-density lipoprotein and triglycerides, and lower levels of high-density lipoprotein cholesterol.
Cholesterol efflux capacity remained inversely associated with incident atherosclerotic cardiovascular disease without attenuation in an adjusted model.
Compared with noncarriers, heterozygous carriers of the ASGR1 mutation had a lower level of non-high-density lipoprotein cholesterol and a 34% lower risk of coronary artery disease
High HDL cholesterol was associated with 20% to 40% lower cardiovascular disease risk compared with isolated low HDL cholesterol, except when triglycerides and LDL cholesterol were elevated.
Watson Pharmaceuticals Inc. received approval to market generic rosuvastatin calcium in multiple strengths for certain uses.
Higher cholesterol levels yielded lower colorectal cancer risks, regardless of statin use.
Mean reductions in low-density lipoprotein cholesterol ranged from -26.9% to -55.5% and triglyceride reductions ranged from -15.1% to -31.3%.
For every 30 mg/dL reduction in cholesterol, researchers found the odds of dying during the study increased by 22%.
Remnant cholesterol predicted coronary artery disease events univariately among patients with diabetes and without, even after adjustment for presence and extent of baseline disease.
Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.
